Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

Laura McDonald, MB MRCPI, Peter McCarthy, MB BCh BAO, Mohammad Khan, MD, Patrick Hogan, MB BCh BAO, Eileen C. Kelleher, MD, Philip Murphy, MD, John Quinn, MD PhD, Ronan Desmond, MD, Johnny McHugh, MB, FRPATH, Melanie Strickland, BNS, Mary Cahill, MD, Su Wai Maung, MRCP, MBBS, Clodagh Keohane, MD, Desmond O'Neill, MD, Daniel Ryan, MD, Vitaliy Mykytiv, MD, Helen Enright, MD

Blood (2018) 132 (Supplement 1): 5515.

https://doi.org/10.1182/blood-2018-99-113290

Published: 2018

Journal Articles

The Role of Marrow Fibrosis in the Prognosis and Treatment of Myelodysplastic Syndromes: a Single Center Retrospective Study

Emma M Groarke, MRCPI, Su Wai Maung, MRCP, MBBS, FRCPath, Karl Ewins, MRCPI, Michael Jeffers, FRCPath, Johnny McHugh, FRCPath, Ronan Desmond, MD FRCPath, Helen Enright, MD FRCPI, FRCPath

Blood (2016) 128 (22): 5524.

https://doi.org/10.1182/blood.V128.22.5524.5524

Published: 2016

Journal Articles

Increased p53 Expression in Patients with Therapy-Related MDS/AML Is Common and May be Associated with a Poor Prognosis

Su Wai Maung, MBBS, MRCP(UK), Niamh Strahan, MSc, Sarah O'Dowd, M.Sc, John O'Loughlin, Ronan Desmond, MD FRCPath, Johnny McHugh, FRCPath, Michael Jeffers, FRCPath, Helen Enright, MD FRCPI, FRCPath

Blood (2015) 126 (23): 5245.

https://doi.org/10.1182/blood.V126.23.5245.5245

Published: 2015

Journal Articles

Clinical Characteristics, Treatment and Outcomes for Patients with Myelodysplastic Syndromes and Chromosome 5q Abnormalities in the Republic of Ireland

Su Wai Maung, MBBS, MRCP(UK), Cian McEllistrim, MRCPI, Amjad Hayat, MBBS, MRCP, FRCPath, PhD, Margaret Murray, FRCPath, Michael O'Dwyer, MD, Patrick Thornton, FRCPath, Emma Groarke, MRCPI, Denis O'Keeffe, MD MRCPath, Maeve Leahy, MD MRCPath, Aine Burke, MRCP,MD, Peter O'Gorman, Carmel Weldon, M.Sc, MRCPI, Gerard Crotty, MD FRCPath, Meegahage Ratnakanthi Perera, MDMRCPath,MBBS, Cathie Burke, RN, Johnny McHugh, FRCPath, Helen Enright, MD FRCPI, FRCPath, Ronan Desmond, MD FRCPath

Blood (2015) 126 (23): 5258.

https://doi.org/10.1182/blood.V126.23.5258.5258

Published: 2015

Journal Articles

Changes in p53 Expression By Immunohistochemistry during Azacitidine Therapy in Patients with MDS Can Predict Overall Prognosis

Su Wai Maung, MBBS, MRCP(UK), Niamh Strahan, M.Sc, Philomena O'Byrne, M.Sc, Sarah O'Dowd, M.Sc, John O'Loughlin, Ronan Desmond, MD FRCPath, Johnny McHugh, FRCPath, Michael Jeffers, FRCPath, Helen Enright, MD FRCPI, FRCPath

Blood (2015) 126 (23): 2878.

https://doi.org/10.1182/blood.V126.23.2878.2878

Published: 2015

Journal Articles

Multicentre Retrospective Analysis of Rituximab Use in the Treatment of Steroid Resistant Autoimmune Haemolytic Anaemia in Ireland,

Su Wai Maung, MBBS, MRCP(UK), Denis O'Keeffe, MD, MRCPath, Maeve Leahy, MD, MRCPath, Hilary M O'Leary, MBBChBAO, MRCPI, MRCPath, Irfan Khan, Mary Cahill, FRCPath, Oonagh Galligan, FRCPath, Philip Murphy, MD, MRCPath, Janusz Krawczyk, MRCPI, Suzanne McPherson, MRCPI, J F Jackson, FRCPath, Mary Ryan, FRCPath, Brian Hennessy, MRCPath, Aine C Burke, MBBChBAO, MRCPI, Helen Enright, MD, Johnny McHugh, FRCPath

Blood (2011) 118 (21): 3171.

https://doi.org/10.1182/blood.V118.21.3171.3171

Published: 2011

Journal Articles

Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma.

Johnny McHugh, Cathal O’Ceallaigh, Colm Keane, Brian W. Otridge, Peter O’Gorman

Blood (2006) 108 (11): 5120.

https://doi.org/10.1182/blood.V108.11.5120.5120

Published: 2006

Journal Articles

Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma.

Johnny McHugh, Colm Keane, Brian W. Otridge, Patrick Thornton, Peter O’Gorman

Blood (2005) 106 (11): 5185.

https://doi.org/10.1182/blood.V106.11.5185.5185

Published: 2005

Journal Articles

Whole Body MRI Versus Skeletal Survey in Multple Myeloma.

Johnny McHugh, Ciaran Johnston, Deirdre Duke, Patrick Thornton, Steve Eustace, Peter O’Gorman

Blood (2005) 106 (11): 5106.

https://doi.org/10.1182/blood.V106.11.5106.5106

Published: 2005

NARROW

Should Myelodysplastic Syndromes in Very Old Patients be More Actively Managed? Clinical Characteristics, Management and Outcomes for Patients 85 Years and Older

The Role of Marrow Fibrosis in the Prognosis and Treatment of Myelodysplastic Syndromes: a Single Center Retrospective Study

Increased p53 Expression in Patients with Therapy-Related MDS/AML Is Common and May be Associated with a Poor Prognosis

Clinical Characteristics, Treatment and Outcomes for Patients with Myelodysplastic Syndromes and Chromosome 5q Abnormalities in the Republic of Ireland

Changes in p53 Expression By Immunohistochemistry during Azacitidine Therapy in Patients with MDS Can Predict Overall Prognosis

Multicentre Retrospective Analysis of Rituximab Use in the Treatment of Steroid Resistant Autoimmune Haemolytic Anaemia in Ireland,

Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma.

Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma.

Whole Body MRI Versus Skeletal Survey in Multple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only